Aerobic bacterial profi le and antibiotic resistance in patients with diabetic foot infections

Revista da Sociedade Brasileira de Medicina Tropical

Volumn 48, Issue 5, 2015, Pages 546-554

  Perim, Michele Cezimbra ^a   Borges, Joelma da Costa ^a   Celeste, Stela Regina Costa ^a,b   Orsolin, Ederson de Freitas ^b   Mendes, Rafael Rocha ^a   Mendes, Gabriella Oliveira ^a   Ferreira, Roumayne Lopes ^a,c   Carreiro, Solange Cristina ^a   Da Silva Pranchevicius, Maria Cristina ^d  

^a UNIVERSIDADE FEDERAL DO TOCANTINS   (Brazil)

^b Hospital Geral de Palmas   (Brazil)

^c Laboratório Central de Saúde Pública Do Tocantins   (Brazil)

^d FEDERAL UNIVERSITY OF SÃO CARLOS   (Brazil)

Author keywords

Diabetic foot infection; Multidrug resistant organisms; Polymicrobial infections

Indexed keywords

CEFOXITIN; GENTAMICIN; IMIPENEM; VANCOMYCIN; ANTIINFECTIVE AGENT;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; CITROBACTER; CLINICAL ARTICLE; DIABETIC FOOT; DISK DIFFUSION; ENTEROBACTER; ESCHERICHIA COLI; FEMALE; HUMAN; MALE; MINIMUM INHIBITORY CONCENTRATION; PREVALENCE; PROSPECTIVE STUDY; PROTEUS; PSEUDOMONAS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS SAPROPHYTICUS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS PNEUMONIAE; CLASSIFICATION; DRUG EFFECTS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; YOUNG ADULT;

ADULT; AGED; ANTI-BACTERIAL AGENTS; DIABETIC FOOT; DRUG RESISTANCE, BACTERIAL; FEMALE; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84947426562     PISSN: 00378682     EISSN: None     Source Type: Journal    
DOI: 10.1590/0037-8682-0146-2015     Document Type: Article

References (48)

1. Sivanmaliappan TS, Sevanan M. Antimicrobial susceptibility patterns of Pseudomonas aeruginosa from diabetes patients with foot ulcers. Int J Microbiol 2011; 2011:605195. (Accessed 2014 January 14). Available at http://www.hindawi.com/journals/ijmicro/2011/605195/
2. Lipsky BA, Berendt AR, Deery HG, Embil JM, Joseph WS, Karchmer AW, et al. Diagnosis and treatment of diabetic foot infections. Clin Infect Dis 2004; 39:885-910
3. Lavery LA, Armstrong DG, Murdoch DP, Peters EJ, Lipsky BA. Validation of the Infectious Diseases Society of America’s diabetic foot infection classifi cation system. Clin Infect Dis 2007; 44:562-565
4. Kandemir O, AkbaySahin E, Millan A, Gen R. Risk factor for infection of the diabetic foot with multi-antibiotic resistant microorganisms. J Infect 2007; 54:439-445
5. El-Tahawy AT. Bacteriology of diabetic foot infections. Saudi Medical J 2000; 21:344-347
6. Hartemann-Heurtier A, Robert J, Jacqueminet S, Ha VG, Golmard JL, Jarlier V, et al. Diabetic foot ulcer and multidrug-resistant organisms: risk factors and impact. Diabet Med 2004; 21:710-715
7. Gentry LO. Diagnosis and management of diabetic foot ulcer. J Antimicrob Chemother 1993; 32 (supl A):77-89
8. Koneman WK, Allen SD, Janda WM, Schreckenberger PC, Propcop GW, Woods GL, et al. Gram-Positive Cocci, Part 1: Staphylococci and Related Gram-Positive Cocci. In: Koneman EW, editor. Koneman´s color atlas and textbook of diagnostic microbiology. 6th ed. USA: Lippincott Williams and Wilkins; 2005. p. 624-662
9. Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing: twenty-fi rst informational supplement. M100-S21. Wayne, PA: CLSI; 2011
10. Clinical and Laboratory Standards Institute (CLSI). Suggested Grouping of US-FDA Approved Antimicrobial Agents That Should Be Considered for Routine Testing and Reporting on Nonfastidious Organisms by Clinical Laboratories, M100-S23. Wayne, PA: CLSI; 2013
11. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing by disk diffusion. Wayne, PA: CLSI; 2007. p. 1987-1998
12. Ruoff KL, Whiley RA, Beighton D. Streptococcus. In: Murray PR, Bureau S, Koster J, Vandenberg L, Pengilley Z, editors. Topley & Wilson's Microbiology & Microbial infections. 10th ed. London: Hodder Arnold; 2005. p. 1435-1457
13. Wang SH, Sun ZL, Guo YJ, Yang BQ, Yuan Y, Wei Q, et al. Meticillin-resistant Staphylococcus aureus isolated from foot ulcers in diabetic patients in a Chinese care hospital: risk factors for infection and prevalence. J Med Microbiol 2010; 59:1219-1224
14. Centers for Disease Control and Prevention (CDC). Healthcare Infection Control Practices Advisory Committee (HICPAC); Atlanta: CDC; 2006. (Accessed 2014 January 15). Available at: http://www.cdc.gov/hicpac/pdf/MDRO/Pages5_6MDROGuideline2006.pdf
15. Harrison PF, Lederberg J. Antimicrobial Resistance: Issues and Options eds. Washington, DC: Forum on Emerging Infections; 1998. p. 8-74
16. Lipsky BA. A report from the international consensus on diagnosing and treating the infected diabetic foot. Diabetes Metab Res Rev 2004; 20 (supl 1):68-77
17. Lipsky BA, Pecoraro RE, Ahroni JH. Foot ulceration and infections in elderly diabetics. Clin Geriatr Med 1990; 6:747-769
18. Hobizal KB, Wukich DK. Diabetic foot infections: current concept review. Diabet Foot Ankle 2012; 3:10.3402/dfa.v3i0.18409. (Accessed 2014 January 20). Available at: http://diabeticfootandankle.net/index.php/dfa/article/view/18409
19. Donoso MTV, Rosa EG, Borges EL. Perfil dos Pacientes com Pé Diabético de um Serviço Público de Saúde. J Nurs UFPE 2013; 7:4740-4746
20. Senneville E, Melliez H, Beltrand E, Legout L, Valette M, Cazaubiel M, et al. Culture of percutaneous bone biopsy specimens for diagnosis of diabetic foot osteomyelitis: concordance with ulcer swab cultures. Clin Infect Dis 2006; 42:57-62
21. Candel González FJ, Alramadan M, Matesanz M, Diaz A, González-Romo F, Candel I, et al. Infections in diabetic foot ulcers. Eur J Intern Med 2003;14:341-343
22. Abdulrazak A, Bitar ZI, Al-Shamali AA, Mobasher LA. Bacteriological study of diabetic foot infections. J Diab Comp 2005; 19:138-141
23. Gadepalli R, Dhawan B, Kapil A. A clinico-microbiological study of diabetic foot ulcers in an Indian tertiary care hospital. Diab Care 2006; 29:1727-1732
24. Singh SK, Gupta K, Tiwari S, Shahi SK, Kumar S, Kumar A, et al. Detecting aerobic bacterial diversity in patients with diabetic foot wounds using ERIC-PCR: a preliminary communication. The Int J Low Extrem Wounds 2009; 8:203-208
25. Citron DM, Goldstein EJC, Merriam VC, Lipsky BA. Bacteriology of moderate to severe diabetic foot infections and invitro activity of anti microbial agents. J Clin Microbiol 2007; 45:2819-2828
26. Lipsky BA, Aragón-Sánchez J, Diggle M, Embil J, Kono S, Lavery L, et al. On behalf of the International Working Group on the Diabetic Foot. International Working Group on the Diabetic Foot (IWGDF); 2015. (Accessded 2015 August 5). Available at: http://www.iwgdf.org/files/2015/website_infection.pdf
27. Dhanasekaran G, Sastry G, Viswanathan M. Microbial pattern of soft tissue infections in diabetic patients in South India. Asian J Diabet 2003; 5:8-10
28. Anandi C, Aaguraja D, Natarajan V, Ramanatham M, Subramaniam CS, Thulasiram M, et al. Bacteriology of diabetic foot lesions. Ind J Med Microbiol 2004; 22:175-178
29. Lipsky BA. New developments in diagnosing and treating diabetic foot infections. Diabetes Metab Res Rev 2008; 24:S66-S71
30. Cornia PB, Lipsky BA. Diabetic Foot Infections. (Accessed 2015 August 8). Antimicrobe; 2011. Available at: http://www. antimicrobe.org/e26.asp
31. Gottrup F, Apelqvist J, Bjansholt T, Cooper R, Moore Z, Peters EJG, et al. EWMA Document: Antimicrobials and Non-healing Wounds - Evidence, controversies and suggestions. J Wound Care 2013; 22 (supl 5):81-89
32. Tentolouris N, Petrikkos G, Vallianou N, Zachos C, Daikos GL, Tsapogas P, Markou G, Katsilambros N. Prevalence of methicillinresistant Staphylococcus aureus in infected and uninfected diabetic foot ulcers. Clin Microbiol Infect 2006; 12:186-189
33. Goldstein EJ, Citron DM, Nesbit CA. Diabetic foot infections: bacteriology and activity of 10 oral antimicrobial agents against bacteria isolated from consecutive cases. Diab Care 1996; 19:638-641
34. Shankar EM, Mohan V, Premalatha G, Srinivasan RS, Usha AR. Bacterial etiology of diabetic foot infections in South India. Eur J Int Med 2005; 16:567-570
35. Lavery LA, Fontaine JL, Bhavan K, Kim PJ, Williams JR, Hunt NA. Risk factors for methicillin-resistant Staphylococcus aureus in diabetic foot infections. Diabet Foot Ankle 2014; 5:23575. (Accessed 2014 December 12). Available at: http://diabeticfootandankle.net/index.php/dfa/article/view/23575
36. Gardete S, Kim C, Hartmann BM, Mwangi M, Roux CM, Dunman PM, et al. Genetic pathway in acquisition and loss of vancomycin resistance in methicillin resistant Staphylococcus aureus (MRSA) strain of clonal type USA300. PLoS Pathog 2012; 8:e1002505
37. Banashankari GS, Rudresh HK, Harsha AH. Prevalence of Gram Negative Bacteria in Diabetic Foot –A Clinico-Microbiological Study. Al Ameen J Med Sci 2012; 5:224-232
38. Senior BW. Proteus, Morganella, and Providencia. In: Balows A, Duerden BI, editors. Topley and Wilson's microbiology and microbial infections. 9th ed. London: Arnold; 1998. p. 1035-1050
39. Umadevi S, Kumar S, Joseph NM, Easow JM, Kandhakumari G, Srirangaraj S, et al. Microbiological Study of Diabetic Foot Infections. Indian J Med Specialities 2011; 2:12-17
40. Rafay AM, Al-Muharrmi, Z, Toki R. Prevalence of extendedspectrum b-lactamases producing isolates over a 1-year period at a university hospital in Oman. Saudi Med J 2007; 28:22-27
41. Rajalakshmi V, Amsaveni V. Antibiotic susceptibility of bacterial pathogens isolated from diabetic patients. Int J Microbiol Res 2011; 2:273-275
42. Gales AC, Reis AO, Jones RN. Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and colistin: review of available interpretative criteria and quality control guidelines. J Clin Microbiol 2001; 39:183-190
43. Gales AC, Jones RN, Sader HS. Global assessment of the antimicrobial activity of polymyxin B against 54 731 clinical isolates of Gram-negative bacilli: report from the SENTRY antimicrobial surveillance programme (2001-2004). Clin Microbiol Infect 2006; 12:315-321
44. Ibrahim EH, Sherman G, Ward S, Fraser VJ, Kollef MH. The infl uence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 2000; 118:146-155
45. Harris AD, McGregor JC, Johnson JA, Strauss SM, Moore AC, Standiford HC, et al. Risk factors for colonization with extendedspectrum β-lactamase-producing bacteria and intensive care unit admission. Emerg Infect Dis 2007; 13:1144-1149
46. Lipsky BA, Giordano P, Choudhri S, Song J. Treating diabetic foot infections with sequential intravenous to oral moxifl oxacin compared with piperacillin-tazobactam/amoxicillin-clavulanate. J Antimicrob Chemother 2007; 60:370-376
47. Lipsky BA. Diabetic foot infections: microbiology made modern? Array of hope. Diabetes Care 2007; 30:2171-2172
48. Lipsky BA, Berendt AR, Cornia PB, Pile JC, Peters EJ, Armstrong DG, et al. Infectious Diseases Society of America: Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis 2012; e132-e173.